Spanish registry following people with digestive tumours across Spain
Records the features of digestive cancers in adults treated at Spanish hospitals.
Plain-language title generated from the registry record
Registry title: Spanish Registry of Digestive Tumours RETUD
Key facts
- Where
- Madrid, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a digestive cancer, such as cancer of the oesophagus, stomach, pancreas, liver, bile duct, bowel or anus. It is an observational study that collects information about their disease.
- Age
- 18 years or older
- Sex
- Men and women can join.
- Disease stage
- Diagnosed with oesophageal, gastric, pancreatic, liver (hepatocarcinoma), gallbladder or bile duct, small intestine, appendix, gastrointestinal stroma, colorectal or anal canal cancer, or a hereditary digestive cancer.
Main reasons for not taking part
- People for whom the information needed for the data collection cannot be known or obtained.
- People who have not given written informed consent.
Read by machine on 12 November 2026.
Where in Spain
- Grupo de Tratamiento de los Tumores Digestivos (TTD)Madrid, SpainContact: Esther Mahillo, PhDTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
- Trial code
- NCT06711211
- Record updated
- 2 December 2024
- Original description
The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients.Read full original descriptionShow less
A Descriptive, Multicentre, Observational Epidemiological Study on Digestive Tumours
The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients.
The study will investigate the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across healthcare centres in Spain. It also aims to generate knowledge and scientific evidence for events and situations that may impact on patients with digestive tumours (e.g. COVID-19 coronavirus pandemic).
Furthermore, subject to the patient's consent, biological samples may be collected for use in translational research projects and for the identification of molecular markers that may be useful in healthcare decision-making.
Inclusion: Male and female patients ≥18 years old diagnosed with oesophageal cancer, gastric cancer, pancreatic cancer, hepatocarcinoma, gallbladder and bile duct cancer, cancer of the small intestine, appendix and gastrointestinal stroma, colorectal cancer, anal canal cancer or digestive hereditary cancer; Written informed consent available.
Exclusion: Patient for whom, for whatever reason, it is not possible to know or obtain the information necessary to complete the data collection base.